| Original language | English |
|---|---|
| Article number | A7 |
| Journal | European Respiratory Journal |
| Volume | 58 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 1 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. / Han, Yueh Ying; Forno, Erick; Bacharier, Leonard B.; Phipatanakul, Wanda; Guilbert, Theresa W.; Cabana, Michael D.; Ross, Kristie; Blatter, Joshua; Rosser, Franziska J.; Durrani, Sandy; Luther, James; Wisniewski, Stephen R.; Celedón, Juan C.
In: European Respiratory Journal, Vol. 58, No. 4, A7, 01.10.2021.Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels
AU - Han, Yueh Ying
AU - Forno, Erick
AU - Bacharier, Leonard B.
AU - Phipatanakul, Wanda
AU - Guilbert, Theresa W.
AU - Cabana, Michael D.
AU - Ross, Kristie
AU - Blatter, Joshua
AU - Rosser, Franziska J.
AU - Durrani, Sandy
AU - Luther, James
AU - Wisniewski, Stephen R.
AU - Celedón, Juan C.
N1 - Funding Information: Conflict of interest: Y-Y. Han has nothing to disclose. E. Forno has nothing to disclose. L.B. Bacharier has nothing to disclose. W. Phipatanakul reports personal fees for consultancy from GSK, Genentech, Novartis, Regeneron, Sanofi and Teva, grants from Genentech, Novartis, Regeneron, Sanofi, Circassia, Monaghen, Thermo Fisher, Alk Abello, Lincoln Diagnostics, GSK, Kaleo and Merck, institutional grants from Genentech, Regeneron, Novartis and the US NIH, outside the submitted work. T.W. Guilbert reports personal fees for consultancy from American Board of Pediatrics (Pediatric Pulmonary Sub-board), GSK, TEVA and Sanofi/Regeneron, grants from AstraZeneca, Novartis and Sanofi/Regeneron, non-financial support from Up To Date, outside the submitted work. M.D. Cabana is a member of the United States Preventive Services Task Force (USPSTF), outside the submitted work. K. Ross has nothing to disclose. J. Blatter has nothing to disclose. F.J. Rosser has nothing to disclose. S. Durrani has nothing to disclose. J. Luther has nothing to disclose. S.R. Wisniewski has nothing to disclose. J.C. Celedón reports non-financial support (study medication) from Pharmavite and GSK, during the conduct of the study; non-financial support (study medication) from Merck, outside the submitted work. Funding Information: Support statement: This study was funded by grant HL119952 from the US National Institutes of Health (NIH). The project was also supported by the Pediatric Clinical and Translational Research Center (PCTRC) at the University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh through NIH grant UL1TR001857. F.J. Rosser’s contribution was supported by grant KL2 TR001856 from the NIH. Pharmavite LLC provided the vitamin D and placebo capsules for the study, and GlaxoSmithKline provided the Flovent given to study participants. Funding information for this article has been deposited with the Crossref Funder Registry.
PY - 2021/10/1
Y1 - 2021/10/1
UR - http://www.scopus.com/inward/record.url?scp=85119457106&partnerID=8YFLogxK
U2 - 10.1183/13993003.00989-2021
DO - 10.1183/13993003.00989-2021
M3 - Letter
C2 - 34326185
AN - SCOPUS:85119457106
VL - 58
JO - European Respiratory Journal
JF - European Respiratory Journal
SN - 0903-1936
IS - 4
M1 - A7
ER -